Target intelligence / Profile preview

Somatic afferent nerve

Molecular classification
Other
01

Overview

Somatic afferent nerves are sensory neurons that transmit information from the periphery—specifically the skin, skeletal muscles, and joints—to the central nervous system (StatPearls, Physiology, Somatic Nervous System). They are responsible for conveying various sensory modalities, including touch, pressure, temperature, pain (nociception), and the position of body parts (proprioception). These nerves are categorized by their diameter and myelination into different fiber types, such as A-alpha, A-beta, A-delta, and C fibers, each specializing in different speeds and types of sensory transmission (PubMed, Sensory Neuron Anatomy). In various disease states, such as diabetes or trauma, these nerves can become damaged or hypersensitized, leading to chronic neuropathic pain or loss of sensation (NIH, Peripheral Neuropathy). From a pharmacological perspective, they are frequently targeted by local anesthetics like lidocaine to block pain signals by inhibiting voltage-gated sodium channels, or by neuromodulators like gabapentin that affect calcium channel signaling. While 'somatic afferent nerves' refers to an anatomical structure rather than a single molecule, they contain numerous specific therapeutic targets, including ion channels and G protein-coupled receptors.

Other names
Somatic sensory nerveAfferent sensory neuronPeripheral afferent nerve fiberSomatic afferent fiber
02

Mechanism of action

Inhibition of voltage-gated sodium channels (e.g., NaV1.7, NaV1.8), modulation of voltage-gated calcium channels (alpha-2-delta subunit), and activation/desensitization of transient receptor potential (TRP) channels.

03

Biological functions

Signal transductionNociceptionProprioceptionMechanoreceptionThermoreceptionSensory perception
04

Disease associations

Chronic painNeuropathic painPeripheral neuropathyNeuralgiaAllodyniaHyperalgesia
05

Safety considerations

Local anesthetic systemic toxicity (LAST)ParesthesiaPermanent nerve damage or neurotoxicityAccidental motor blockadeLoss of protective sensation
06

Interacting drugs

Lidocaine

7 more in the full profile.

07

Biomarkers

Nerve conduction velocity (NCV)Intraepidermal nerve fiber density (IENFD)Quantitative sensory testing (QST)Skin biopsy (PGP 9.5 staining)

Beyond the preview

Go deeper on Somatic afferent nerve.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Somatic afferent nerve.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call